Search alternatives:
point decrease » point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
24801
HE images of the adherent cells in the 2D and 3D scaffold systems.
Published 2024“…Cells within SHE (5x magnification) reach 60% confluence at 24h (p) and a 100% confluence at 72h (q). Instead, in SHR1 (5x magnification), SHR2 and SHR3 (10x magnification) the cells barely reached 50% confluence at 72h, then the cellularity decreased between 72h and 7 days (j-o). 2D culture (5x magnification) show a higher cellularity in each time point compared to scaffolds (a-c). …”
-
24802
Elicitation of the hippocampal theta by the stimuli.
Published 2014“…Shown are the averages across all the trials for each stimulus type in the session 10 of a rat (50 trials each). x axis, time (in s); y axis, frequency (in Hz). …”
-
24803
Defective spermatogenesis and altered expression of CREB in CF mice testis.
Published 2011“…Bar = 20 µm (upper panel) or 50 µm (lower panel). (<b>E</b>) Statistic shows slight decrease in tubular diameter is observed in −/− testes. …”
-
24804
Development of the cell fitness multiplexing assay.
Published 2011“…Luminescence signals (black) reach a maximum ten minutes after addition of CTG (see step 7 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0028338#pone-0028338-g001" target="_blank">Fig. 1A</a>) followed by linear decrease. …”
-
24805
DataSheet1_Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder.docx
Published 2024“…Background<p>In the treatment of depression, medication plays a crucial role. However, insufficient patient adherence to medication often results in unsatisfactory treatment outcomes, increasing both the recurrence and rehospitalization rates of depression, and consequently imposing a greater economic burden on the healthcare system.…”
-
24806
Characterization of phenotypically unique accessions.
Published 2025“…The map was created with data from Natural Earth via the R package <i><i>rnaturalearth</i></i> [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003536#pbio.3003536.ref030" target="_blank">30</a>] (basemap shapefile: <a href="https://www.naturalearthdata.com/downloads/50m-cultural-vectors/" target="_blank">https://www.naturalearthdata.com/downloads/50m-cultural-vectors/</a>). …”
-
24807
-
24808
-
24809
-
24810
-
24811
-
24812
-
24813
-
24814
-
24815
-
24816
-
24817
-
24818
Data_Sheet_1_SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway.doc
Published 2020“…In this study, we show that SWL-1 reverses resistance to fluconazole in C. albicans when delivered in combination, with a sharp decrease in the IC<sub>50</sub> of fluconazole from >200 to 3.74 ± 0.25 μg/ml, and also reverses the fluconazole resistance of C. albicans in vitro, with IC<sub>50</sub> from >200 to 5.3 ± 0.3 μg/ml. …”
-
24819
An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers
Published 2011“…Simulations of the verified model surfaced important therapeutic insights: (1) Fractionating the standard daily regimen (50 µg/dose) into a twice daily schedule (25 µg/dose) is advantageous, yielding a significantly lower tumor mass (45% decrease); (2) A low-dose (12 µg/day) regimen exerts a response similar to that obtained under the 50 µg/day treatment, suggestive of an equally efficacious dose with potentially reduced toxicity. …”
-
24820